c-semaglutide/niacinamide Oral semaglutide drops leaving a non Semaglutide Injection Mechanism of Action:

The pill uses the same active ingredient semaglutide that powers the original Wegovy, along with its sister drug for diabetes, Ozempic

Cht chng oxy ha ny gip c ch enzyme tyrosinase, cht kch hot sn xut tng sc t eumelanin (melanin en), mang li ln da sng hn v rng r hn

It reached the market in 2026 for overweight and obesity, with a diabetes use under review, and is widely expected to expand access because of its oral form and supply profile

Weight management in eligible overweight adults who have at least one weight-related health condition

Selectively interacts with ghrelin (GHS-R1a) receptors in research models

T., Rubino, D